Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ballentine

Showing results (81-90 of 451) with videos related to

Pageof 46
Sort By:
Asian Journal of Andrology|April 24, 2012
Helping to address the over treatment of prostate cancer: tools to differentiate lethal and non-lethal phenotype in prostate cancerRobert H Getzenberg, H Ballentine Carter
Urology|December 23, 2014
Reply: To PMID 25440986Katarzyna J Macura, H Ballentine Carter
Integrative Organismal Biology (Oxford, England)|June 17, 2024
The Meioflume: A New System for Observing the Interstitial Behavior of MeiofaunaW M Ballentine, K M Dorgan
The Journal of Urology|November 7, 2006
The discovery of prostate specific antigen as a biomarker for the early detection of adenocarcinoma of the prostateDanil V Makarov, H Ballentine Carter
Health Affairs (Project Hope)|December 5, 2022
How Low-Paid Parents Navigate The Complex Financial Landscape Of Benefits Cliffs And Disincentive DesertsKess Ballentine, Sara Goodkind, Jeffrey Shook
BJU International|June 7, 2014
Multiparametric magnetic resonance imaging (MRI) and active surveillance for prostate cancer: future directionsJeffrey K Mullins, H Ballentine Carter
The Journal of Urology|December 6, 2014
Re: Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screeningH Ballentine Carter, Peter C Albertsen
Journal of the American Pharmacists Association : Japha|December 31, 2005
Judging a book by its cover: the predicament with Canadian pharmacy advertisements and American consumersAmanda J Ballentine, Earlene E Lipowski
European Urology|February 21, 2018
Risk Stratification in Active Surveillance: A Dynamic, Ever-Evolving PracticeJeffrey J Tosoian, H Ballentine Carter
Urology|November 22, 2015
ReplyAdam C Reese, H Ballentine Carter
Pageof 46

Showing results (81-90 of 451) with videos related to

Sort By:
Pageof 46
Asian Journal of Andrology|April 24, 2012
Helping to address the over treatment of prostate cancer: tools to differentiate lethal and non-lethal phenotype in prostate cancerRobert H Getzenberg, H Ballentine Carter
Urology|December 23, 2014
Reply: To PMID 25440986Katarzyna J Macura, H Ballentine Carter
Integrative Organismal Biology (Oxford, England)|June 17, 2024
The Meioflume: A New System for Observing the Interstitial Behavior of MeiofaunaW M Ballentine, K M Dorgan
The Journal of Urology|November 7, 2006
The discovery of prostate specific antigen as a biomarker for the early detection of adenocarcinoma of the prostateDanil V Makarov, H Ballentine Carter
Health Affairs (Project Hope)|December 5, 2022
How Low-Paid Parents Navigate The Complex Financial Landscape Of Benefits Cliffs And Disincentive DesertsKess Ballentine, Sara Goodkind, Jeffrey Shook
BJU International|June 7, 2014
Multiparametric magnetic resonance imaging (MRI) and active surveillance for prostate cancer: future directionsJeffrey K Mullins, H Ballentine Carter
The Journal of Urology|December 6, 2014
Re: Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screeningH Ballentine Carter, Peter C Albertsen
Journal of the American Pharmacists Association : Japha|December 31, 2005
Judging a book by its cover: the predicament with Canadian pharmacy advertisements and American consumersAmanda J Ballentine, Earlene E Lipowski
European Urology|February 21, 2018
Risk Stratification in Active Surveillance: A Dynamic, Ever-Evolving PracticeJeffrey J Tosoian, H Ballentine Carter
Urology|November 22, 2015
ReplyAdam C Reese, H Ballentine Carter
Pageof 46